Page 203 - Read Online

Berezin. Vessel Plus 2018;2:22 I http://dx.doi.org/10.20517/2574-1209.2018.23 Page 7 of 10

Conflicts of interest
The author declares that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Diederichs C, Neuhauser H. Regional variations in hypertension prevalence and management in Germany: results from the German
Health Interview and Examination Survey (DEGS1). J Hypertens 2014;32:1405-13.
2. de Burgos-Lunar C, Jiménez-García R, Salinero-Fort MA, Gómez-Campelo P, Gil A, Abánades-Herranz JC, Cárdenas-Valladolid J, del
Cura-González I. Trends in hypertension prevalence, awareness, treatment and control in an adult type 2 diabetes Spanish population
between 2003 and 2009. PLoS One 2014;9:e86713.
3. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between
developing and developed countries. J Hypertens 2009;27:963-75
4. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment,
and control in the WHO SAGE study. Hypertension 2013;62:18-26.
5. Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, Facchetti R, Redon J, Mancia G, Grassi G. Prevalence
and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J
Hypertens 2013;31:2018-24.
6. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:
2043-50.
7. Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Douma S. Clinical significance of endothelial dysfunction in essential hypertension. Curr
Hypertens Rep 2015;17:85.
8. Bernatova I. Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence? Biomed Res Int
2014;2014:598271.
9. Brandes RP. Endothelial dysfunction and hypertension. Hypertension 2014;64:924-8.
10. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.
Biomed Res Int 2014;2014:406960.
11. de Faria AP, Fontana V, Modolo R, Barbaro NR, Sabbatini AR, Pansani IF, Ferreira-Melo SE, Moreno H. Plasma 8-isoprostane levels
are associated with endothelial dysfunction in resistant hypertension. Clin Chim Acta 2014;433:179-83.
12. Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, Lee J, Lee MY, Lee SM, Kang DH, Lee BH. Uric acid induces endothelial
dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J 2014;28:3197-204.
13. Wong WT, Tian XY, Huang Y. Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent
COX-2-derived prostanoids. J Cardiovasc Pharmacol 2013;61:204-14.
14. Martynowicz H, Janus A, Nowacki D, Mazur G. The role of chemokines in hypertension. Adv Clin Exp Med 2014;23:319-25.
15. Berezin AE. Preconditioned endothelial progenitor cells as biomarker of vascular reparation? Insights in Biomed 2017;2:4-7.
16. Shan Y, Lin J, Xu P, Zeng M, Lin H, Yan H. The combined effect of hypertension and type 2 diabetes mellitus on aortic stiffness and
endothelial dysfunction: an integrated study with high-resolution MRI. Magn Reson Imaging 2014;32:211-6.
17. Jamwal S, Sharma S. Vascular endothelium dysfunction: a conservative target in metabolic disorders. Inflamm Res 2018;67:391-405.
18. Triches CB, Mayer S, Quinto BMR, Batista MC, Zanella MT. Association of endothelial dysfunction with cardiovascular risk factors
and new-onset diabetes mellitus in patients with hypertension. J Clin Hypertens (Greenwich) 2018; doi: 10.1111/jch.13269.
19. Berezin AE. Endothelial progenitor cells dysfunction and impaired tissue reparation: the missed link in diabetes mellitus development.
Diabetes Metab Syndr 2017;11:215-20.
20. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative
progenitor endothelial cells for angiogenesis. Science 1997;275:964-6.
21. Asahara T. Endothelial progenitor cells for vascular medicine. Yakugaku Zasshi 2007;127:841-5. [in Japanese]
22. Patel J, Donovan P, Khosrotehrani K. Concise review: functional definition of endothelial progenitor cells: a molecular perspective.
Stem Cells Transl Med 2016;5:1302-6.
23. Yi C, Xia W, Zheng Y, Zhang L, Shu M, Liang J, Han Y, Guo S. Transplantation of endothelial progenitor cells transferred by vascular
endothelial growth factor gene for vascular regeneration of ischemic flaps. J Surg Res 2006;135:100-6.